Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies

Immune checkpoint inhibitors (ICIs) are reshaping the landscape of cancer treatment, redefining the prognosis of several tumors. They act by restoring the cytotoxic activity of tumor-specific T lymphocytes that are in a condition of immune exhaustion. The same condition has been widely described in...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelli, Valeria, Lombardi, Andrea, Palomba, Emanuele, Bozzi, Giorgio, Ungaro, Riccardo, Alagna, Laura, Mangioni, Davide, Muscatello, Antonio, Bandera, Alessandra, Gori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467545/
https://www.ncbi.nlm.nih.gov/pubmed/34571876
http://dx.doi.org/10.3390/cells10092227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467545/
https://www.ncbi.nlm.nih.gov/pubmed/34571876
http://dx.doi.org/10.3390/cells10092227

Ejemplares similares